Evidence map›Paper›PMID 40188229›Full record

ArticleBone marrow transplantation2025

Outcomes of attenuated dose fludarabine and melphalan based conditioning regimen in patients undergoing allogeneic stem cell transplant: a propensity score-matched analysis.

Anmol Baranwal, Rabee Kassis, Khalil Hassan, Jade Kutzke, Gabriel Bartoo, Robert Wolf, Aasiya Matin, Mehrdad Hefazi Torghabeh, Abhishek Mangaonkar, Mark R Litzow and 4 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Bone marrow transplantation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Anmol BaranwalDivision of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-3432-0489
Rabee KassisDivision of Hematology, Mayo Clinic, Rochester, MN, USA.
Khalil HassanDivision of Hematology, Mayo Clinic, Rochester, MN, USA.
Jade KutzkeDepartment of Pharmacy, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0003-1115-274X
Gabriel BartooDepartment of Pharmacy, Mayo Clinic, Rochester, MN, USA.
Robert WolfDepartment of Pharmacy, Mayo Clinic, Rochester, MN, USA.
Aasiya MatinDivision of Hematology, Mayo Clinic, Rochester, MN, USA.
Mehrdad Hefazi TorghabehDivision of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0001-8860-3380
Abhishek MangaonkarDivision of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0003-2458-9887
Mark R LitzowDivision of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-9816-6302
Mithun V ShahDivision of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-5359-336X
William J HoganDivision of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-5841-4105
David DingliDivision of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0001-7477-3004
Hassan B AlkhateebDivision of Hematology, Mayo Clinic, Rochester, MN, USA. Alkhateeb.Hassan@mayo.edu.ORCID http://orcid.org/0000-0002-3609-8404

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40188229
PMCPMC12151860

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.